Addus Homecare Corp expected to post earnings of $1.17 a share - Earnings Preview

Addus HomeCare

23/02/2024 21:19

* Addus Homecare Corp  ADUS.OQ   ADUS.O  is expected to show
a
rise in quarterly revenue when it reports  results on February
26 for the period ending December 31 2023
    * The Frisco Texas-based  company is expected to report a
11.1% increase in revenue to $274.443 million from $247.05
million a year ago, according to the mean estimate from 8
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Addus Homecare Corp is
for
earnings of $1.17 per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 8 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Addus
Homecare
Corp is $108.00​, above​ its last closing price of $90.00. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  1.09        1.08       1.15      Beat    6.2
 Jun. 30 2023  1.01        1.01       1.07      Beat    5.9
 Mar. 31 2023  0.90        0.88       0.97      Beat    10.9​
 Dec. 31 2022  0.95        0.95       1.11      Beat    16.4
 ​​Sep.        0.92        0.92       0.94      Beat    2.1
 30 2022                                                
 Jun. 30 2022  0.92        0.90       0.91      Beat    1.4​
 Mar. 31 2022  0.76        0.74       0.77      Beat    3.5
 Dec. 31 2021  0.94        0.92       0.97      Beat    5.4
 This summary was machine generated February 23 at 21:19 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)